{
}
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Innovent Biologics has secured a $1 billion licensing agreement with Roche for the development of IBI3009, a DLL3-targeted antibody-drug conjugate aimed at advanced small cell lung cancer. The deal includes an $80 million upfront payment, with potential milestone payments and royalties based on sales. IBI3009, developed using Innovent's TOPO1i platform, has shown promising anti-tumor activity and a favorable safety profile in preclinical studies.
Innovent Biologics has entered a billion-dollar collaboration with Roche to develop IBI3009, a DLL3-targeted antibody drug conjugate for advanced small cell lung cancer. The agreement grants Roche exclusive global rights, with Innovent receiving an $80 million upfront payment and potential milestone payments up to $1 billion. IBI3009 has shown promising anti-tumor activity and a favorable safety profile in preclinical models.
Merck has cut the price of its diabetes drug Januvia by 42%, aiming to align list prices with net prices and responding to changes in the Medicaid rebate program. Meanwhile, Neumora's experimental depression drug failed in a Phase 3 study, causing an 83% drop in its stock. Roche is expanding its presence in the antibody-drug conjugate space through a deal with Innovent Biologics, which could yield up to $1 billion in milestone payments.
Roche has entered a $1 billion deal with Innovent Biologics for the DLL3-targeted ADC IBI3009, following promising data from Zai Lab's DLL3 ADC in small cell lung cancer. AstraZeneca faces scrutiny in China, potentially impacting operations, while Viatris received an FDA warning letter for its Indian plant, affecting 11 products. In other developments, Ideaya Biosciences is paying $75 million for rights to SHR-4849, and Hutchmed is divesting its interest in a traditional medicine unit to focus on ADCs.
Innovent Biologics, Inc.
Companies
United States Dollar
Innovent Biologics, Inc.
Hoffmann-La Roche AG
AUS
CHN
USA
Samuel Zhang
Show more
07:52 06.01.2025
Chinese Yuan
United States Dollar
Australian Dollar
Innovent Biologics, Inc.
Hoffmann-La Roche AG
AUS
CHN
USA
Show more
07:15 05.01.2025
United States Dollar
Merck & Co., Inc.
Innovent Biologics, Inc.
Hoffmann-La Roche AG
CHN
USA
Wilma Lee Cooper
Elaine Chen
Allison DeAngelis
Show more
15:34 03.01.2025
VBI Vaccines Inc.
Shanghai Pharmaceuticals Holding Co., Ltd
Hoffmann-La Roche AG
Lonza Group AG
AstraZeneca PLC
I-Mab
SK bioscience Co.,Ltd.
Zai Lab Ltd
IDEAYA Biosciences, Inc.
Brii Biosciences Ltd.
HUTCHMED
Sanofi
BeiGene, Ltd.
Innovent Biologics, Inc.
Viatris Inc.
Cytokinetics, Incorporated
CHN
IND
Yong Ying-I
Pascal Soriot
Show more
14:37 03.01.2025
Trending
Subcategory:
Cryptocurrency Markets
Cryptocurrency Trends
Stock Market Updates
Market Sentiment Analysis
Decentralized Finance (DeFi) Innovations
Central Bank Actions
Market Analysis and Predictions
Tokenomics and Crypto Economics
Inflation Rates & CPI Data
Hedge Funds & Private Equity
Cryptocurrency & Blockchain Regulations
Banking Regulations
Employment Reports
Cryptocurrency Regulations
Anti-Money Laundering (AML) Regulations
ESG & Sustainable Finance Regulations
Corporate Responsibility & ESG
Anti-Money Laundering (AML) & Know Your Customer
Blockchain Technology Adoption
Banking & Investment Regulations
Countries:
Companies:
Currencies:
People:
Apple Inc.
Ethereum USD
Solana USD
Ripple USD USD
Bitcoin USD
Coinbase Global, Inc.
Santiment Network Token USD
Bitwise Bitcoin ETF
NVIDIA Corporation
Ripples USD
JPMorgan Chase & Co.
BlackRock, Inc.
MicroStrategy Inc
Taiwan Semiconductor Manufacturing Co Ltd
Chainlink USD
Grayscale Bitcoin Trust ETF
Heritage Distilling Holding Company, Inc.
Robinhood Markets, Inc.
MARATHON DIGITAL
End Federal Reserve USD
United States Dollar
Armenian Dram
Euro
Vietnamese Đồng
British Pound Sterling
Canadian Dollar
New Zealand Dollar
Australian Dollar
Philippine Peso
Malagasy Ariary
Japanese Yen
Singapore Dollar
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.